David A. Siegel Teva Pharmaceutical Industries LTD Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,034,500 shares of TEVA stock, worth $17.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,034,500

Previous 897,500 15.26%

Holding current value

$17.7 Million

Previous $14.6 Million 27.82%

% of portfolio

0.05%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $2.17 Million - $2.6 Million	137,000 Added 15.26%	1,034,500 $18.6 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $639,000 - $869,999	-50,000 Reduced 5.28%	897,500 $14.6 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $712,756 - $963,924	-66,800 Reduced 6.59%	947,500 $13.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $234,667 - $307,207	-28,900 Reduced 2.77%	1,014,300 $10.6 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $1.72 Million - $2.47 Million	-230,600 Reduced 18.1%	1,043,200 $10.6 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $1.27 Million - $1.67 Million	-176,200 Reduced 12.15%	1,273,800 $9.59 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $9.28 Million - $12.6 Million	-1,110,500 Reduced 43.37%	1,450,000 $12.8 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $1.11 Million - $1.33 Million	-139,800 Reduced 5.18%	2,560,500 $23.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $9.22 Million - $16.1 Million	1,344,100 Added 99.11%	2,700,300 $21.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $757,188 - $1.07 Million	-102,600 Reduced 7.03%	1,356,200 $10.2 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $676,559 - $866,697	92,300 Added 6.75%	1,458,800 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $8.96 Million - $11.6 Million	1,134,600 Added 489.26%	1,366,500 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $1.94 Million - $2.36 Million	231,900 New	231,900 $2.26 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $3.3 Million - $3.85 Million	-333,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $1.69 Million - $2.1 Million	-163,900 Reduced 32.97%	333,200 $3.85 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $2.1 Million - $2.69 Million	-244,000 Reduced 32.92%	497,100 $4.8 Million
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $2.39 Million - $3.53 Million	-278,500 Reduced 27.31%	741,100 $6.68 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $8.44 Million - $13.6 Million	-1,039,100 Reduced 50.47%	1,019,600 $12.6 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $6.05 Million - $12.2 Million	904,800 Added 78.41%	2,058,700 $18.5 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $7.53 Million - $12.4 Million	1,153,900 New	1,153,900 $11.3 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $1.58 Million - $3.06 Million	-194,399 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $352,092 - $452,205	22,599 Added 13.15%	194,399 $3.05 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $2.82 Million - $4.61 Million	-193,299 Reduced 52.94%	171,800 $2.65 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $63.2 Million - $77 Million	-3,002,500 Reduced 89.16%	365,099 $7.86 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $8.44 Million - $12.4 Million	-503,400 Reduced 13.0%	3,367,599 $81.9 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $39.7 Million - $52.6 Million	-2,381,600 Reduced 38.09%	3,870,999 $66.2 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $70.2 Million - $119 Million	6,252,599	6,252,599 $118 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account